| Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics R Khetan, R Curtis, CM Deane, JT Hadsund, U Kar, K Krawczyk, ... MAbs 14 (1), 2020082, 2022 | 43 | 2022 |
| Ab-Ligity: identifying sequence-dissimilar antibodies that bind to the same epitope WK Wong, SA Robinson, A Bujotzek, G Georges, AP Lewis, J Shi, ... MAbs 13 (1), 1873478, 2021 | 36 | 2021 |
| Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies SA Robinson, MIJ Raybould, C Schneider, WK Wong, C Marks, ... PLoS computational biology 17 (12), e1009675, 2021 | 33 | 2021 |
| The allosteric modulation of complement C5 by knob domain peptides A Macpherson, M Laabei, Z Ahdash, MA Graewert, JR Birtley, ... Elife 10, e63586, 2021 | 24 | 2021 |
| Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshop O Ball, S Robinson, KIM Bure, DA Brindley, D Mccall Cytotherapy 20 (4), 592-599, 2018 | 19 | 2018 |
| EU market authorisation strategy: lessons from the first 22 ATMP submitted to the EMA CA Bravery, O Ball, S Robinson Cell Gene Ther. Insights 5, 759-791, 2019 | 14 | 2019 |
| Epitope profiling of coronavirus-binding antibodies using computational structural modelling SA Robinson, MIJ Raybould, C Schneider, WK Wong, C Marks, ... bioRxiv, 2021.04. 12.439478, 2021 | 8 | 2021 |
| Making the grade: untangling the myths of raw materials used for the manufacture of cell-and gene-based medicinal products B Bravery, S Robinson, S Burger Cell Gene Ther. Insights 4 (3), 207-25, 2018 | 5 | 2018 |
| Isolation and molecular identification of nematode surface mutants with resistance to bacterial pathogens D O’Rourke, MJ Gravato-Nobre, D Stroud, E Pritchett, E Barker, RL Price, ... G3: Genes, Genomes, Genetics 13 (5), jkad056, 2023 | 3 | 2023 |
| The changing regulatory landscape for laboratory developed tests. Regulatory Affairs Professionals Society (RAPS); 2021 SA Robinson, AR Carter, DA Brindley | 2 | |
| Bacterial endotoxin testing of drugs and biologics in the US: Ensuring patient safety SA Robinson, AR Carter, DA Brindley Regulatory Focus, 2023 | | 2023 |
| Leveraging BCR data to improve computational design of therapeutic antibodies S Robinson University of Oxford, 2023 | | 2023 |
| Expedited Regulatory Pathway Options and Utility: Pandemic to Endemic. S Robinson, A Carter, D Brindley Regulatory Focus, 2022 | | 2022 |
| Epitope profiling of coronavirus-binding antibodies using computational structural modelling (preprint) SA Robinson, MIJ Raybould, C Marks, C Schneider, WK Wong, ... | | 2021 |
